Search
Close this search box.
Search
Close this search box.
Search
Close this search box.

Fine Foods at CPHI 2025: Innovation and New Synergies

Fine Foods & Pharmaceuticals N.T.M. S.p.A. will showcase its new brand identity and innovative holistic approach to well-being at CPHI 2025 in Frankfurt, highlighting synergies between the nutraceutical, pharmaceutical, and cosmetics sectors. Through strategic investments, expanded production with capacity and a strong focus on research and development, the company is positioning itself as a leading integrated Health & Beauty solutions provider.

The 2025 CPHI Frankfurt, taking place from 28–30 October, is just around the corner. Fine Foods & Pharmaceuticals N.T.M. S.p.A. (Euronext STAR Milan: FF) is setting up its latest innovations and refreshed corporate positioning to be presented to an international audience. For the Italian independent Contract Services Development & Manufacturing Organization (CSDMO), specialising in the contract development and manufacturing of products for the nutraceutical, pharmaceutical, and cosmetics industries with a customer-centric, service-oriented philosophy, the event provides an ideal stage to demonstrate how nutraceutical and cosmetic solutions can integrate with the pharmaceutical world to deliver a holistic concept of well-being. Pharmaceutical brands are increasingly expanding their portfolios to include nutraceutical and cosmetic lines as strategic extensions. These sectors allow accelerating innovation, experimenting with new communication styles and responding to emerging market demands while using the authority of their parent brand.

Visitors to the Fine Foods stand will see the Group’s new brand identity, first introduced in May with its new logo. This helps strengthen its unique position on the market. The updated brand features the “Health & Beauty CSDMO” payoff alongside the “Fine Foods” naming. The addition of the “S” for Services highlights the company’s enduring commitment to providing high value-added, service-oriented solutions across its business sectors.

A holistic approach to well-being

At CPHI, Fine Foods will showcase its expertise through products representing the three Group’s core business units. A significant example is the women’s area, that will be highlighted through cosmetic and nutraceutical ranges designed to help women at all stages of life, responding to their specific needs. From adolescence to post-menopause, the solutions combine supplements and cosmetics synergistically, promoting well-being from the inside out. A dedicated line of intimate cleansers, tailored to women’s different needs, works alongside functional cosmetics and supplements, which are available in a variety of galenic preparations, including capsules and powders. These are formulated to support holistic well-being.

The focus extends to oral and topical formulations designed to ease symptoms and support overall well-being in synergy with traditional pharmaceuticals. Innovative supplements target specific needs such as headaches, joint pain, or gastrointestinal disorders, providing comprehensive health support. Functional topical products complete the range. These are formulated to address issues such as heavy legs, sensitive gums, or fatigued joints, using different types of technology, including solid sticks, for targeted and complementary action.

Fine Foods will highlight other areas of nutraceutical innovation, including biotics (an emerging frontier in health) and solutions for metabolic syndrome, explored in its various subcategories.

The solutions stem from the Group’s commitment to research and development, a cornerstone of its growth strategy. Fine Foods introduction of the CSDMO concept underscores its dedication to offering a complete range of premium services, including:

  • Industry expertise: Decades of experience across the nutraceutical, pharmaceutical and cosmetics sectors.
  • Strategic guidance and marketing support: Helping customers effectively define their market strategies.
  • Cutting-edge innovation and formulation development: A proactive R&D team constantly anticipating new trends.
  • Regulatory advice and certification support: Essential assistance in navigating complex regulatory environments.
  • Quality analysis and control: Rigorous standards to ensure the highest quality of finished products.
  • Structured project management: One contact provides the customer with the planning, coordination and monitoring of each project phase, for clear, efficient, and secure delivery.

The recent rebranding embodies Fine Foods’ core values: reliability, modernity, dynamism, excellence, quality, ethics, integrity, sustainability, innovation and attention to detail. These principles form the foundation of the company’s ability to respond comprehensively to customer needs and to build long-term partnerships.

Business Unit Growth and Consolidation

Fine Foods commitment to strengthening its product range is reflected in its recent strategic investments. The completion of the new pharmaceutical plant in Brembate (Bergamo) marks a significant milestone. Following the recent inspection by AIFA, the company expects final authorisation for the start-up of the new production site by the end of the year. This expansion will enable Fine Foods to fulfil major multi-year agreements signed with international customers, and accelerate the development of the Pharma Business Unit, responding effectively to the growing demand within this rapidly expanding market.

Fine Foods is investing to increase its nutraceutical production capacity by purchasing new land needed for further facility extensions.

The Cosmetics Business Unit has reached a crucial stage in its evolution. Following the acquisition of Euro Cosmetic, now rebranded as Fine Cosmetics, the Group has undertaken substantial investments in upgrading production facilities and strengthening its management team with the addition of highly experienced professionals. The Group is investing in R&D by creating a second cosmetics laboratory, the “Research and Innovation Hub”, with a surface area nearly three times larger than the existing facility. This new centre will reinforce Fine Cosmetics’ position as a strategic partner for leading brands in the global beauty and personal care industry.

Market trends point towards an increasing convergence between nutraceuticals and cosmetics, and the Group is working with several customers whose product portfolios span both sectors.

CPHI 2025 is the ideal platform to demonstrate how Fine Foods has evolved into a comprehensive solutions provider within the Health & Beauty sector. Fine Foods is actively shaping the future of the health and beauty landscape through a model built on innovation, synergy and outstanding customer service.

Share the Post:

Related Posts

Fine Foods at CPHI 2025: Innovation and New Synergies

Fine Foods & Pharmaceuticals N.T.M. S.p.A. will showcase its new brand
identity and innovative holistic approach to well-being at CPHI 2025 in
Frankfurt, highlighting synergies between the nutraceutical, pharmaceutical,
and cosmetics sectors. Through strategic investments, expanded production
with capacity and a strong focus on research and development, the company is
positioning itself as a leading integrated Health & Beauty solutions provider.

Read More

Valeovita – One Door to Open for Your Private Label Food Supplements

In today’s nutraceutical market, speed, flexibility, and trust are more important than ever. Brands and retailers seeking to expand their product portfolio are often faced with a complex journey: finding reliable raw material suppliers, researching formulations, navigating regulatory frameworks, managing production, and ensuring full compliance with quality documentation.

Read More